161822-04-4

Basic information

• Product Name: (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide
• Synonyms: (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide
• CAS NO: 161822-04-4
• Molecular Formula: C22H46N8O8
• Molecular Weight: 550.6494
• Mol File: 161822-04-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 863.6°Cat760mmHg
• Flash Point: 476.1°C
• Appearance: /
• Density: 1.42g/cm³
• Vapor Pressure: 8.86E-35mmHg at 25°C
• Refractive Index: 1.632
• CAS DataBase Reference: (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide(161822-04-4)
• EPA Substance Registry System: (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide(161822-04-4)

Safety Data

• Hazardous Substances Data: 161822-04-4(Hazardous Substances Data)

Usage

General Description

The chemical compound "(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide" is a complex organic molecule that contains amino groups and hydroxyl groups. It is composed of cyclohexyl, butanamide, and various amino sugar moieties. (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6- (hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide is likely to have biological activity and may be involved in biological processes such as protein synthesis or cell signaling. Its detailed structure suggests that it may have a role in the formation or modification of glycoproteins or glycolipids. Further research is needed to understand its specific biological function and potential applications.

InChI:InChI=1/C22H46N8O8/c23-4-3-12(32)20(34)30-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)16(29)19(11)38-22-15(28)14(27)17(33)13(7-31)36-22/h8-19,21-22,31-33H,1-7,23-29H2,(H,30,34)/t8-,9+,10-,11+,12-,13+,14+,15+,16+,17+,18+,19-,21+,22+/m0/s1

Upstream product

• 1055036-39-9 4'',6'',2'''-tri-O-acetyl-3,2',6',3'',4'''-pentakis(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxy-5-O-mesylarbekacin 
• 161822-11-3 4'',6'',2'''-tri-O-acetyl-3,2',6',3'',4'''-pentakis(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-5,2''-dideoxy-5-epiazidoarbekacin 

Relevant articles and documents

Synthesis of 2'-amino-2'-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus

Based on our studies on the enzymatic modifications of arbekacin by methicillin-resistant Staphylococcus aureus (MRSA), replacement of the 2'-hydroxyl group by an amino group in arbekacin was designed to synthesize derivatives that would be active against